You went for a routine health check. Or perhaps your GP suggested a blood test. The report comes back and one line reads: PSA — elevated. Maybe someone mentioned the word cancer. Now you are reading this at midnight, not sure what to think.
Let me explain what is actually happening — clearly, without jargon, and without either alarming you unnecessarily or minimising something that does deserve attention.
1. What is PSA — and what does it actually measure?
PSA stands for Prostate-Specific Antigen. It is a protein produced almost exclusively by the prostate gland — a small, walnut-sized gland that sits just below the bladder in men. Its job in the body is to liquefy semen after ejaculation.
Normally, very small amounts of PSA leak into the bloodstream. A PSA blood test measures how much is circulating. The key word in the name is prostate-specific — not cancer-specific. PSA is made by prostate cells in general, not just cancerous ones.
This distinction matters enormously — and it is the source of most of the confusion surrounding PSA testing.
PSA is a marker of prostate activity, not a marker of cancer. Many conditions cause PSA to rise — most of them benign. An elevated PSA means your prostate is drawing attention to itself. It does not tell us why.
2. What does an elevated result actually mean?
Think of PSA as a smoke detector. When it goes off, something is causing it to go off — but that something might be a fire (cancer), or it might be steam from a shower (infection, enlarged prostate, recent exertion). Your job — with your doctor — is to find the source of the smoke.
An elevated PSA tells us one thing with certainty: the prostate needs to be evaluated further. It does not tell us there is cancer. It does not tell us there is not. It is a starting point for investigation, not a conclusion.
Studies show that even when PSA is significantly elevated — say, between 4 and 10 ng/mL — only about 25–30% of men who go on to have a biopsy are found to have prostate cancer. The majority have a benign explanation.
3. Understanding the numbers
PSA is measured in nanograms per millilitre (ng/mL). There is no universally "normal" PSA — values must be interpreted in the context of your age, prostate size, and rate of change over time. That said, here is a general guide:
| PSA Level | General Interpretation | What typically follows |
|---|---|---|
| Under 2.5 ng/mL | Generally reassuring in men under 60 | Routine follow-up; repeat in 1–2 years |
| 2.5–4 ng/mL | Low normal to borderline; age-dependent | Discuss with urologist; consider repeat in 6–12 months |
| 4–10 ng/mL | Mildly elevated — the "grey zone" | MRI prostate; further evaluation by urologist |
| 10–20 ng/mL | Significantly elevated | MRI + biopsy discussion; specialist referral |
| Above 20 ng/mL | Highly elevated — warrants prompt attention | Urgent urological evaluation; staging workup |
A PSA that rises from 2 to 4 over 12 months is often more concerning than a stable PSA of 5 over several years. Always share previous PSA reports with your urologist — the trend is as important as the current value.
PSA density — size matters
A larger prostate naturally produces more PSA. A PSA of 6 ng/mL in a man with a very enlarged prostate (say, 80 grams) is much less concerning than the same value in a man with a small prostate (25 grams). PSA density — PSA divided by prostate volume — helps account for this. Your urologist will calculate this from your ultrasound or MRI.
Free PSA ratio
PSA circulates in two forms: bound to proteins, and free. In prostate cancer, a higher proportion tends to be bound — meaning the free PSA ratio (free PSA ÷ total PSA) tends to be lower. A free PSA ratio below 10% is more suspicious; above 25% is generally reassuring. This is a useful additional test in the grey zone of 4–10 ng/mL.
4. Other causes of elevated PSA — that are not cancer
This is the section I most want you to read carefully. These are common, benign causes of PSA elevation:
Benign Prostatic Hyperplasia (BPH): The most common cause of elevated PSA in older men. An enlarged prostate — which affects most men over 60 — produces more PSA simply because there is more prostate tissue. This is benign and very treatable.
Prostatitis: Inflammation or infection of the prostate. Can cause PSA to rise dramatically — sometimes to 20, 30, even 50 ng/mL — from what is essentially a benign, treatable condition. If you have had urinary symptoms, discomfort, or fever recently, tell your doctor. PSA should be repeated after treating prostatitis.
Recent ejaculation: Sexual activity within 48 hours of a PSA test can transiently elevate PSA. Not dramatically, but enough to matter in borderline cases. PSA tests are ideally done after 48 hours of abstinence.
Vigorous exercise: Particularly cycling. Pressure on the perineum (the area between the legs) can elevate PSA. Avoid strenuous cycling for 48 hours before the test.
Digital Rectal Examination (DRE): A prostate examination just before the blood draw can falsely elevate PSA. Blood should ideally be drawn before the examination, or at a separate visit.
Urinary catheter or recent cystoscopy: Any instrumentation of the urinary tract can elevate PSA temporarily.
If there is any possibility that one of the above factors affected your result, ask your doctor whether it is worth repeating the test under controlled conditions before proceeding further. A single elevated reading in the wrong context should not trigger a biopsy.
5. What happens next — the investigation pathway
If your PSA is elevated and the result is confirmed on repeat testing, here is what a systematic investigation typically looks like:
Consultation with a urologist
A urologist will review your PSA in context — your age, family history, symptoms, prostate size on examination, and any previous PSA values. This conversation determines whether further investigation is needed and how urgently.
mpMRI of the prostate
A multiparametric MRI (mpMRI) is now the standard investigation before any biopsy decision. It is a specialised scan that provides detailed images of the prostate and can identify suspicious areas. It is not painful, does not involve radiation, and takes about 30 minutes. Crucially, it helps avoid unnecessary biopsies in many men.
Risk stratification using MRI findings (PIRADS score)
The radiologist assigns a PIRADS score (1–5) to any lesion seen on MRI. PIRADS 1–2 is very unlikely to be cancer. PIRADS 4–5 is highly suspicious. This score, combined with your PSA and clinical factors, guides the biopsy decision.
Prostate biopsy — if indicated
A biopsy samples prostate tissue to check for cancer under the microscope. Modern biopsies are increasingly MRI-fusion targeted — the MRI image is overlaid onto the ultrasound in real time, directing the biopsy needle precisely to the suspicious area. This is more accurate than the older random biopsy approach.
If cancer is found — staging and treatment planning
If the biopsy confirms cancer, the next step is staging — understanding how extensive the cancer is. This may involve a PSMA PET-CT scan or bone scan. Treatment options are then discussed in detail, based on the cancer's characteristics and your personal priorities.
6. Common myths, corrected
7. Questions to ask your doctor at your next appointment
Walking into a consultation prepared makes a significant difference. Here are the questions worth asking:
Take this list with you
- What is my PSA density — how does my PSA compare to the size of my prostate?
- What was my PSA last time — is it rising, stable, or falling? How fast?
- Should I have a free PSA ratio test?
- Do I need an MRI before any biopsy is considered?
- Is there anything that may have caused a false elevation — infection, recent catheter, exercise?
- What are my risk factors — family history, ethnicity, age?
- If we watch and wait, what am I watching for — what would trigger the next step?
- If a biopsy is recommended, what type — random or MRI-fusion targeted?
In summary
An elevated PSA is a reason to see a urologist — not a reason to panic. It is a signal from your prostate that something has changed, and that change needs to be understood.
The investigation pathway is well-defined, increasingly precise, and designed to answer one clear question: is this cancer, and if so, does it need treatment? Modern tools — particularly the mpMRI — have made that answer much more accurate than it was even a decade ago.
If you have received an elevated PSA result and have not yet seen a urologist, that is the most important next step. Bring your reports, bring your questions, and ask for an explanation you can actually understand.
The two most common mistakes after an elevated PSA are ignoring it entirely and spiralling into anxiety without getting proper evaluation. Both delay the clarity you deserve. See a urologist, get the MRI if indicated, and make an informed decision from there.
This article is written for educational purposes and reflects general medical knowledge as of 2026. It does not constitute personalised medical advice and does not establish a doctor-patient relationship. PSA values and investigation pathways must be interpreted in the context of your individual clinical situation by a qualified urologist. If you have concerns about your PSA or prostate health, please consult a urological surgeon.